Delany-Moretlwe, S., Hughes, J. P., Bock, P., Ouma, S. G., Hunidzarira, P., Kalonji, D., Kayange, N., Makhema, J., Mandima, P., Mathew, C., Spooner, E., Mpendo, J., Mukwekwerere, P., Mgodi, N., Ntege, P. N., Nair, G., Nakabiito, C., Nuwagaba-Biribonwoha, H., Panchia, R., … Gaffoor, Z. (2022). Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. The Lancet, 399(10337), 1779–1789. https://doi.org/10.1016/s0140-6736(22)00538-4
Columbia Affiliation:
Subjects:
Publication Type:
Article
Unique ID:
10.1016/S0140-6736(22)00538-4
PMID:
Journal:
Publication Date:
Data Source:
Scopus